Oncobiotix Inc.

Oncobiotix Inc. is a biotechnology company developing oral drugs that help improve the efficacy of cancer treatments like immunotherapy. The company is tackling a major challenge in cancer care: while many patients receive immunotherapy, the majority do not respond, often because of the required dosing of antibiotics or the presence of an unhealthy gut microbiome that decreases the efficacy of the treatment. What sets Oncobiotix apart is that its drugs are inspired by the body’s natural microbiome, meaning they are safe, scalable, and effective even for patients with disrupted microbiomes. Oncobiotix offers a scalable, precise, and safe therapeutic alternative poised to improve clinical outcomes and expand the patient market. Relevance to Patients: Oncobiotix Inc. is developing oral drugs that restore the effectiveness of cancer immunotherapy, especially in patients with disrupted gut microbiomes or prior antibiotic use.